116 related articles for article (PubMed ID: 3133879)
1. Studies on the procurement of blood coagulation factor VIII. In vivo studies on blood components prepared in half-strength citrate anticoagulant.
Griffin B; Bell K; Prowse C
Vox Sang; 1988; 54(4):193-8. PubMed ID: 3133879
[TBL] [Abstract][Full Text] [Related]
2. Studies on the procurement of blood coagulation factor VIII in vitro studies on blood components prepared in half-strength citrate anticoagulant.
Prowse C; Waterston YG; Dawes J; Farrugia A
Vox Sang; 1987; 52(4):257-64. PubMed ID: 3114954
[TBL] [Abstract][Full Text] [Related]
3. Studies on the procurement of blood coagulation factor VIII. In vitro studies on blood components prepared in half-strength citrate anticoagulant 18 hours after phlebotomy.
Griffin B; Bell K; Prowse C
Vox Sang; 1988; 55(1):9-13. PubMed ID: 3138819
[TBL] [Abstract][Full Text] [Related]
4. In vivo viability of red blood cells stored in CPDA-2.
Sohmer PR; Moore GL; Beutler E; Peck CC
Transfusion; 1982; 22(6):479-84. PubMed ID: 7147326
[TBL] [Abstract][Full Text] [Related]
5. Storage of red cell concentrates in CPD-A2 for 42 and 49 days.
Beutler E; West C
J Lab Clin Med; 1983 Jul; 102(1):53-62. PubMed ID: 6854134
[TBL] [Abstract][Full Text] [Related]
6. A clinical trial of red-cell concentrate prepared from blood collected in half-strength citrate anticoagulant.
Murphy WG; Palmer JB; Wilson R; Prowse CV; McClelland DB
Transfus Med; 1991 Mar; 1(1):25-9. PubMed ID: 9259823
[TBL] [Abstract][Full Text] [Related]
7. Characterization of biochemical changes occurring during storage of red cells. Comparative studies with CPD and CPDA-1 anticoagulant-preservative solutions.
Moroff G; Dende D
Transfusion; 1983; 23(6):484-9. PubMed ID: 6649025
[TBL] [Abstract][Full Text] [Related]
8. Posttransfusion survival of red cells frozen for 8 weeks after 42-day liquid storage in AS-3.
Rathbun EJ; Nelson EJ; Davey RJ
Transfusion; 1989; 29(3):213-7. PubMed ID: 2922788
[TBL] [Abstract][Full Text] [Related]
9. In vivo survival of platelets prepared in CPD anticoagulant.
Tranum BL; Haut A
Transfusion; 1972; 12(3):168-74. PubMed ID: 5026168
[No Abstract] [Full Text] [Related]
10. Survival and biochemical characteristics of stored red cells preserved with citrate-phosphate-dextrose-adenine-one and two and prepared from whole blood maintained at 20 to 24 degrees C for eight hours following phlebotomy.
Moroff G; Morse EE; Katz AJ; Kahn RA; Dende D; Swatman L; Staggs SD
Transfusion; 1984; 24(2):115-9. PubMed ID: 6710583
[TBL] [Abstract][Full Text] [Related]
11. A clinical evaluation of citrate-phosphate-dextrose-adenine blood.
Kreuger A; Akerblom O; Högman CF
Vox Sang; 1975; 29(2):81-9. PubMed ID: 807039
[TBL] [Abstract][Full Text] [Related]
12. The in vivo survival of red blood cells stored in modified CPD with adenine: report of a multi-institutional cooperative effort.
Zuck TF; Bensinger TA; Peck CC; Chillar RK; Beutler E; Button LN; McCurdy PR; Josephson AM; Greenwalt TJ
Transfusion; 1977; 17(4):374-82. PubMed ID: 878003
[TBL] [Abstract][Full Text] [Related]
13. Red blood cell membrane abnormalities during storage: correlation with in vivo survival.
Schrier SL; Sohmer PR; Moore GL; Ma L; Junga I
Transfusion; 1982; 22(4):261-5. PubMed ID: 7101417
[TBL] [Abstract][Full Text] [Related]
14. The in vitro evaluation of modifications in CPD-adenine anticoagulated-preserved blood at various hematocrits.
Moore GL; Ledford ME; Peck CC
Transfusion; 1980; 20(4):419-26. PubMed ID: 7404640
[TBL] [Abstract][Full Text] [Related]
15. Half-strength citrate CPD combined with a new additive solution for improved storage of red blood cells suitable for clinical use.
Högman CF; Eriksson L; Gong J; Högman AB; Vikholm K; Debrauwere J; Payrat JM; Stewart M
Vox Sang; 1993; 65(4):271-8. PubMed ID: 8310679
[TBL] [Abstract][Full Text] [Related]
16. Whole blood storage in citrate and phosphate solutions containing half-strength trisodium citrate: cellular and biochemical studies.
Mishler JM; Darley JH; Cederholm-Williams S; Wright G
J Pathol; 1978 Mar; 124(3):125-39. PubMed ID: 722376
[TBL] [Abstract][Full Text] [Related]
17. Viability and function of platelet concentrates stored in CPD-adenine (CPDA-1).
Scott EP; Slichter SJ
Transfusion; 1980; 20(5):489-97. PubMed ID: 7423588
[TBL] [Abstract][Full Text] [Related]
18. Metabolic aspects and viability of heparin/CPDA-1-stored red cell concentrate as a by-product of a high-yield factor VIII production method.
de Jonge J; Smit Sibinga CT; Das PC
Haemostasis; 1983; 13(4):214-8. PubMed ID: 6413307
[TBL] [Abstract][Full Text] [Related]
19. Effects of irradiation on red cells stored in CPDA-1 and CPD-ADSOL (AS-1).
Jeter EK; Gadsden RH; Cate J
Ann Clin Lab Sci; 1991; 21(3):177-86. PubMed ID: 1905899
[TBL] [Abstract][Full Text] [Related]
20. Studies on citrate-phosphate-dextrose (CPD) blood supplemented with adenine.
Akerblom O; Kreuger A
Vox Sang; 1975; 29(2):90-100. PubMed ID: 238338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
